Literature DB >> 12443592

Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study.

Caroline A Sabin1, Anja Griffioen, Thynn Thynn Yee, Vincent C Emery, Esteban Herrero-Martinez, Andrew N Phillips, Christine A Lee.   

Abstract

BACKGROUND: Low serum albumin concentration is associated with short-term survival in individuals with HIV-1. However, few investigators have assessed whether individuals with a low serum albumin concentration have delayed progression to AIDS, or survive in the long term. We aimed to assess the relation between markers of liver function and progression to AIDS and death in individuals with haemophilia infected with HIV-1 and hepatitis C virus.
METHODS: We measured markers of liver function and took CD4 counts every 3 months in 111 patients registered at the Royal Free Hospital Haemophilia Centre, London, UK. HIV RNA concentrations were measured yearly and then every 3-6 months from 1996. We used Cox's regression models to assess the independent prognostic value of these markers for AIDS and death.
FINDINGS: As a fixed covariate, albumin concentrations measured shortly after HIV-1 seroconversion were associated with risk of AIDS (relative hazard 0.91 [95% CI 0.84-1.00], p=0.04) and death (0.89 [0.82-0.96], p=0.004) over a 15-year period. These findings were independent of the CD4 count and HIV-1 RNA concentration. As a time-updated covariate, after adjustment for CD4 count and HIV-1 RNA concentrations, albumin was not associated with progression to AIDS (0.96 [0.90-1.01], p=0.13), but was strongly associated with death (0.88 [0.84-0.93], p<0.0001) in the short term.
INTERPRETATION: Low concentrations of albumin in individuals infected with HIV-1 could indicate a poor outlook and should therefore prompt concern at any stage of infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12443592     DOI: 10.1016/S0140-6736(02)11519-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010.

Authors:  James D Neaton; Jacqueline Neuhaus; Sean Emery
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

2.  HIV/AIDS patients display lower relative bioavailability of efavirenz than healthy subjects.

Authors:  Jackson K Mukonzo; Sarah Nanzigu; Dinko Rekić; Paul Waako; Daniel Röshammar; Michael Ashton; Jasper Ogwal-Okeng; Lars L Gustafsson; Eleni Aklillu
Journal:  Clin Pharmacokinet       Date:  2011-08       Impact factor: 6.447

3.  Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among tanzanians initiating antiretroviral therapy.

Authors:  Christopher R Sudfeld; Sheila Isanaka; Said Aboud; Ferdinand M Mugusi; Molin Wang; Guerino E Chalamilla; Wafaie W Fawzi
Journal:  J Infect Dis       Date:  2013-01-14       Impact factor: 5.226

4.  Serum albumin and short-term risk for mortality and cardiovascular disease among HIV-infected veterans.

Authors:  Joshua Lang; Rebecca Scherzer; Cristin C Weekley; Phyllis C Tien; Carl Grunfeld; Michael G Shlipak
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

5.  Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.

Authors:  Ting-Yi Chen; Eric L Ding; George R Seage Iii; Arthur Y Kim
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

6.  A decrease in albumin in early SIV infection is related to viral pathogenicity.

Authors:  Susan M Graham; Sarah Holte; Jason T Kimata; Mark H Wener; Julie Overbaugh
Journal:  AIDS Res Hum Retroviruses       Date:  2009-04       Impact factor: 2.205

7.  Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study.

Authors:  Andreas Ronit; Shweta Sharma; Jason V Baker; Rosie Mngqibisa; Tristan Delory; Luis Caldeira; Nicaise Ndembi; Jens D Lundgren; Andrew N Phillips
Journal:  J Infect Dis       Date:  2018-01-17       Impact factor: 5.226

8.  Association of serum albumin with markers of nutritional status among HIV-infected and uninfected Rwandan women.

Authors:  Jean-Claude Dusingize; Donald R Hoover; Qiuhu Shi; Eugene Mutimura; Elizabeth Kiefer; Mardge Cohen; Kathryn Anastos
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

9.  Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.

Authors:  Wenrui Xue; Yu Zhang; Hua Wang; Yu Zhang; Xiaopeng Hu
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

10.  Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions.

Authors:  Melody E Roelke; Meredith A Brown; Jennifer L Troyer; Hanlie Winterbach; Christiaan Winterbach; Graham Hemson; Dahlem Smith; Randall C Johnson; Jill Pecon-Slattery; Alfred L Roca; Kathleen A Alexander; Lin Klein; Paolo Martelli; Karthiyani Krishnasamy; Stephen J O'Brien
Journal:  Virology       Date:  2009-05-22       Impact factor: 3.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.